Small and mid-cap stocks are in correction mode after posting one of their best July's ever. MapSignals' Alec Young lays out how to play the space. Plus, RXO says a soft freight market is weighing on revenue. CEO Drew Wilkerson explains. And, Eli Lilly reports results today after rival Novo Nordisk warned of pricing pressures in the weight-loss drug industry. Tema ETFs' Maurits Pot discusses the outlook.
Worldwide Exchange